President, CEO and Co-Founder
Gajus V. Worthington is a co-founder of Fluidigm Corporation and has served as President and Chief Executive Officer and as a director since the company's inception in June 1999. From May 1994 to April 1999, he held various staff and management positions at Actel Corporation, a public semiconductor corporation. He received a BS in physics and an MS in electrical engineering from Stanford University.
Chief Financial Officer
Vikram Jog has served as Chief Financial Officer since February 2008. From April 2005 to February 2008, he was Chief Financial Officer for XDx, Inc., a molecular diagnostics company. From March 2003 to April 2005, he was a vice president of Applera Corporation and Vice President of Finance for its related businesses, Celera Genomics and Celera Diagnostics. From April 2001 to March 2003, he was Vice President of Finance for Celera Diagnostics and Corporate Controller of Applera Corporation. Jog holds a Bachelor of Commerce degree from Delhi University and an MBA from Temple University. He is a member of the American Institute of Certified Public Accountants.
Robert C. Jones
Executive VP, Research & Development
Robert C. Jones has served as Executive Vice President for Research and Development since August 2005. From August 1984 to July 2005, he held various managerial and research and development positions at Applied Biosystems, a laboratory equipment and supplies manufacturer that is a division of Applera Corporation. Those positions included Senior Vice President for Research and Development from April 2001 to August 2005, Vice President and General Manager of the informatics division from 1998 to 2001 and Vice President of the PCR business unit from 1994 to 1998. Jones received a BS in electrical engineering and an MS in computer engineering from the University of Washington.
Vice President, European Commercial Operations and General Manager of Fluidigm Europe BV
Dominique Remy-Renou has 20 years of experience in the life science tools business. From 1997 to 2005, she was Country Manager for Applied Biosystems (ABI), France, while concurrently holding pan-European titles for ABI, including Manager of the Molecular Biology Business Unit and Senior Director of Marketing. In these combined roles, she was responsible for sales, support, marketing, finance and administration. In 1987, she joined ABI as a sales engineer and over the next decade and a half was promoted to positions of increasing responsibility. Early in her career, Remy-Renou worked at Spectra Physics, France, and at Kratos, France.
Executive Vice President, Worldwide Manufacturing and Managing Director of Fluidigm Singapore Pte. Ltd.
Mai Chan (Grace) Yow has served as Executive Vice President for Worldwide Manufacturing of Fluidigm Singapore Pte. Ltd., the company's Singapore subsidiary, since January 2012 and as Managing Director of Fluidigm Singapore Pte. Ltd. since March 2006. She served as Vice President for Worldwide Manufacturing from March 2006 to January 2012. From June 2005 to March 2006, she was General Manager of Fluidigm Singapore Pte. Ltd. From August 2004 to May 2005, she served as Vice President for Engineering (Asia) for Kulicke and Soffa, a public semiconductor equipment manufacturer. From March 1991 to July 2004, she was Director of Assembly Operations for Plant Facilities and EHS for National Semiconductor Singapore, a semiconductor fabrication subsidiary of National Semiconductor Corporation. Yow received a BE in electronic engineering from Curtin University, a certificate in management studies from the Singapore Institute of Management and a diploma in electrical engineering from Singapore Polytechnic.
Steven C. McPhail
General Manager, Production Genomics
Steven C. McPhail has served as General Manager, Production Genomics since May 2015. From February 2003 to August 2012, he was President and Chief Executive Officer of Expression Analysis, Inc., a genomic services company that was acquired by Quintiles Transnational Corporation in August 2012, where he was President of the post-acquisition operation until March 2015. Prior to Expression Analysis, Inc., he held various staff and management positions at companies in the diagnostic, biotechnology, and medical device markets, including ArgoMed Inc., Xanthon, Inc., TriPath Imaging Inc., Dynex Technologies, Inc., and Abbott Laboratories. McPhail received a BS in biology from San Diego State University.